– NETHERLANDS, The Hague – Aegon (AEX: AGN) today announced the appointment of Frans Blom to its Supervisory Board.
The Dutch Central Bank approved the proposal which will be submitted for approval at the 2021 Annual General Meeting. Until then, Frans Blom will attend the Supervisory Board meetings as an observer.
“We would like to welcome Frans to Aegon and look forward to working with him on the Supervisory Board. He has held various senior positions in the management consulting industry, and has advised banks, insurance companies and pension providers on developing growth strategies, performance improvement programs, and corporate transformations. This underscores his understanding of business strategy and driving change as well as his in-depth knowledge of the financial services industry”, said Chairman of Supervisory Board, William Connelly.
About Frans Blom
Frans Blom has extensive experience in the management consulting industry, which he acquired during his 30 years of service at Boston Consulting Group, a US-headquartered management consulting firm with a global presence. He has also been serving as a Member of the Supervisory Board of Dutch wealth manager Van Lanschot Kempen since 2018, as of April 2020 in the role of Chairman.
Aegon’s roots go back more than 175 years – to the first half of the nineteenth century. Since then, Aegon has grown into an international company, with businesses in more than 20 countries in the Americas, Europe, and Asia. Today, Aegon is one of the world’s leading financial services organizations, providing life insurance, pensions, and asset management. Aegon’s purpose is to help people achieve a lifetime of financial security.
For more information: https://www.aegonlife.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.